Stock listing
NASDAQ:AVNR Avanir Pharmaceuticals Inc Stock
Follow Avanir Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:AVNR
$16.96 USD
Close on Jan 12, 2015 · No longer trades
- Lowest – highest close
- $0.26 – $36.50 USDSince Jan 4, 1999 · lowest Nov 25, 2008 · highest Oct 2, 2000
Delisted NASDAQ:AVNR no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:AVNR
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Avanir Pharmaceuticals Inc on 6ix
- Decks
- 2 decks · latest Oct 29, 2013
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Day (October 2013) | Investor day | 79 slides | Oct 29, 2013 |
| Technical Presentation (August 2009) | Technical | 31 slides | Aug 11, 2009 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Keith A. Katkin Other companies: Emergent BioSolutions Inc. (Independent Director · Since at least Apr 1, 2022); Eledon Pharmaceuticals, Inc. (Chairman of the Board of Directors · Since at least May 10, 2017); Syndax Pharmaceuticals, Inc. (Director · Since at least Mar 29, 2017); Urovant Sciences Ltd (PEO;CEO/Urovant Sciences, Inc., Director · Sep 26, 2018 – Feb 19, 2020 · Past); Rigel Pharmaceuticals, Inc. (Director · Jun 29, 2015 – May 19, 2021 · Past); Carbylan Therapeutics Inc (Director · Apr 8, 2015 – Aug 3, 2015 · Past) | President and CEO, Director · May 15, 2013 – Dec 15, 2014 · Past |
| Corinne H Nevinny Other companies: Insulet Corporation (Director · Jan 25, 2019 – May 23, 2023 · Past); Neurocrine Biosciences, Inc. (Director · May 29, 2009 – May 24, 2018 · Past); Edwards Lifesciences Corporation (CVP & Pres., Global Ops · Oct 23, 2008 – May 13, 2010 · Past); Onyx Pharmaceuticals Inc (Director · Oct 6, 2008 – Oct 1, 2013 · Past) | Director · Mar 11, 2013 – Feb 12, 2014 · Past |
| Craig A Wheeler Other companies: Apellis Pharmaceuticals, Inc. (Director · Since at least Apr 17, 2025); Amicus Therapeutics Inc (Director · Since at least Jun 9, 2016); Momenta Pharmaceuticals Inc (President & CEO, Director · Aug 22, 2006 – Sep 10, 2020 · Past) | Director · Feb 13, 2006 – Feb 12, 2014 · Past |
| Rohan Palekar Other companies: Neurogene Inc. (Director · Since at least Mar 2, 2022); 89bio Inc (Chief Executive Officer, Director · Since at least Nov 8, 2019); Medivation Inc (Chief Commercial Officer · Jan 14, 2008 – Apr 20, 2011 · Past) | SVP & Chief Commercial Officer · Apr 3, 2012 – Nov 28, 2014 · Past |
| Christine Ocampo Other companies: Urovant Sciences Ltd (PAO; CAO/Urovant Sciences,Inc. · Sep 26, 2018 – Mar 29, 2021 · Past); Eledon Pharmaceuticals, Inc. (See Remarks · May 10, 2017 – May 24, 2017 · Past) | Vice President, Finance · Aug 11, 2010 – Dec 16, 2014 · Past |
| Dennis G. Podlesak Other companies: Syndax Pharmaceuticals, Inc. (Chair of the Board of Directors · Since at least Mar 2, 2016); Tobira Therapeutics Inc (Director · Aug 21, 2013 – Nov 1, 2016 · Past) | Director · Feb 19, 2009 – Feb 12, 2014 · Past |
| Charles Mathews Other companies: Apollo Endosurgery Inc (Director · Apr 21, 2010 – Dec 29, 2016 · Past) | Director · Feb 8, 2011 – Mar 6, 2012 · Past |
Log in to ask 6ix AI your own questions about Avanir Pharmaceuticals Inc.